Brief: Crescita Therapeutics net loss for three months ended Dec. 31, 2016 was $4.1 mln
30/03/2017 12:31
March 30 (Reuters) - Crescita Therapeutics Inc CTX.TO
* Crescita Therapeutics- net loss for three months ended
December 31, 2016 was $4.1 million compared to $4.4 million for
three months ended december 31, 2015
* Crescita Therapeutics- total revenue for three months
ended December 31, 2016 was $2.2 million versus $60,000 for
three months ended december 31, 2015
* Crescita Therapeutics Inc - company is continually
assessing in-licensing, merger and acquisition activities
Source text for Eikon: ID:nPn5XghNfa
Further company coverage: CTX.TO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium